[18F]-6-(ethyl(4-(3-fluoro-2-methylpropoxy)-3-isopropylphenyl)amino)nicotinic acid

ID: ALA3425830

Chembl Id: CHEMBL3425830

PubChem CID: 118736688

Max Phase: Preclinical

Molecular Formula: C21H27FN2O3

Molecular Weight: 374.46

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(c1ccc(OCC(C)C[18F])c(C(C)C)c1)c1ccc(C(=O)O)cn1

Standard InChI:  InChI=1S/C21H27FN2O3/c1-5-24(20-9-6-16(12-23-20)21(25)26)17-7-8-19(18(10-17)14(2)3)27-13-15(4)11-22/h6-10,12,14-15H,5,11,13H2,1-4H3,(H,25,26)/i22-1

Standard InChI Key:  GZUNYNSCGWSKRA-KVTPGWOSSA-N

Associated Targets(non-human)

Kidney (1278 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Stomach (551 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (8163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Duodenum (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Heart (1016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 374.46Molecular Weight (Monoisotopic): 374.2006AlogP: 5.05#Rotatable Bonds: 9
Polar Surface Area: 62.66Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.91CX Basic pKa: 4.41CX LogP: 4.11CX LogD: 1.61
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.67Np Likeness Score: -0.75

References

1. Kobayashi T, Furusawa Y, Yamada S, Akehi M, Takenaka F, Sasaki T, Akahoshi A, Hanada T, Matsuura E, Hirano H, Tai A, Kakuta H..  (2015)  Positron emission tomography to elucidate pharmacokinetic differences of regioisomeric retinoid x receptor agonists.,  (3): [PMID:25815156] [10.1021/ml500511m]

Source